Depo-Provera Lawsuits Update: Birth Control Shot Litigation Advancing Rapidly

The litigation over allegations that the Depo-Provera birth control shot causes a type of brain tumors known as meningioma is moving forward rapidly.
At least 130 lawsuits filed by women with brain tumors after using Depo-Provera have been added to the multi-district litigation (MDL) that was created in Florida to help expedite the legal process for these claims. Several Depo-Provera lawsuits have also been filed in state courts.
Although the Depo-Provera litigation is advancing rapidly, there is still time for women with meningioma brain tumors from the Depo shot to file a lawsuit and receive compensation.
Start your claim today by contacting the lawyers at Hissey Mulderig & Friend. You can reach us by calling our offices toll-free at 1-866-806-8117, or send us a message by filling out the free claims submission form on the right side of this page.
Depo-Provera Litigation Timeline
Concerns about the link between Depo-Provera and brain tumors first arose in March 2024, when a study published by the British Medical Journal (BMJ) revealed that women who were injected with the birth control shot were five times more likely to develop a benign, or non-cancerous, form of brain tumors known as meningiomas.
The first lawsuit against the manufacturers of Depo-Provera was filed in October of that year by a woman who developed brain tumors. The lawsuit alleged that these tumors were caused by the woman’s use of the Depo shot.
After additional lawsuits were filed in California, Florida, Massachusetts, New Jersey, and Pennsylvania, the U.S. Judicial Panel on Multidistrict Litigation centralized the federal Depo-Provera lawsuits in an MDL, located in the U.S. District Court for the Northern District of Florida. So far, there have been 130 Depo-Provera lawsuits added to this litigation.
By consolidating the lawsuits against Depo-Provera in an MDL, the federal court system will be able to organize the evidence-gathering process for this litigation in a single court, making it easier for women with brain tumors from the birth control shot to receive a settlement.
Besides the dozens of lawsuits filed against the makers of Depo-Provera in federal court, some women have elected instead to file claims in various state courts.
Thousands of Depo-Provera Lawsuits Expected to Be Filed
Legal experts have predicted that as many as 16,000-18,000 Depo-Provera lawsuits could eventually be filed by women diagnosed with meningioma brain tumors after using the birth control shot.
While there are still several additional steps in the litigation process before women involved in the Depo-Provera MDL will start receiving settlements, compared to the slow pace of other MDLs, experts say that the federal Depo-Provera lawsuit is advancing at a very rapid pace.
Women who used Depo-Provera, have been diagnosed with meningioma brain tumors, and who wish to join the Depo-Provera litigation or file a claim in state court should contact an attorney to find out if they qualify and start the process of filing their claim.
Contact Our Firm to Start Your Claim Today
Although the federal litigation against Depo-Provera has been moving forward quickly, there is still time for women who were diagnosed with brain tumors after using the birth control shot to file a claim and receive a settlement or other compensation for their injuries.
If you or a loved one were injected with Depo-Provera or Depo-SubQ Provera birth control shots and diagnosed with meningioma brain tumors, you may qualify to file a lawsuit and receive compensation.
Hissey Mulderig & Friend is currently representing several women in the Depo-Provera litigation who were affected by brain tumors after using the birth control shot. Our firm is also speaking with women every day about joining this litigation.
To start the process of filing your claim today and join the lawsuit against Depo-Provera, you can call our office toll-free at 1-866-806-8117, or send us a message by filling out our free claims submission form located at the top of this page.
Last updated on: April 15, 2025

